Approval · Notice of Compliance 36308 · 2024
FAMPYRA: Notice of Compliance 36308
Issued November 3, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 36308
- Date
- November 3, 2024
- Company
- Merz Therapeutics GmbhFrankfurt Am Main, Germany
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative: Change in product ownership
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FAMPYRA | 02379910 | Marketed |
Medicinal ingredients
- FAMPRIDINE 10 MG per TAB